Telomir Pharmaceuticals Inc (NASDAQ:TELO)’s traded shares stood at 0.36 million during the last session. At the close of trading, the stock’s price was $6.52, to imply an increase of 17.06% or $0.95 in intraday trading. The TELO share’s 52-week high remains $20.72, putting it -217.79% down since that peak but still an impressive 52.3% since price per share fell to its 52-week low of $3.11. The company has a valuation of $193.06M, with an average of 0.25 million shares in intraday trading volume over the past 10 days and average of 147.10K shares over the past 3 months.

Telomir Pharmaceuticals Inc (NASDAQ:TELO) trade information

After registering a 17.06% upside in the last session, Telomir Pharmaceuticals Inc (TELO) has traded red over the past five days. The 5-day price performance for the stock is 63.82%, and 41.74% over 30 days. With these gigs, the year-to-date price performance is 30.40%. Short interest in Telomir Pharmaceuticals Inc (NASDAQ:TELO) saw shorts transact 0.65 million shares and set a 11.0 days time to cover.

Telomir Pharmaceuticals Inc (TELO) estimates and forecasts

Looking at statistics comparing Telomir Pharmaceuticals Inc share performance against respective industry, we note that the company has underperformed competitors. Telomir Pharmaceuticals Inc (TELO) shares are 15.81% up over the last 6 months, with its year-to-date growth rate lower than industry average at -20.00% against 16.60%.

TELO Dividends

Telomir Pharmaceuticals Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.